米国の集団健康管理（PHM）市場：製品別（ソフトウェア、サービス）、最終用途別（プロバイダー、支払者、雇用者グループ）の市場規模、シェアおよび動向分析、セグメント別予測（2022年～2030年）

米国の集団健康管理（PHM）の市場規模は、予測期間中に20.8%のCAGRで拡大し、2028年には766億米ドルに達する見込みす。

医療費の増加、価値に基づいた医療提供の必要性、異なる医療現場での効果的な疾病管理などが予測期間中に市場成長を促進する主な要因です。

当レポートでは、米国の集団健康管理（PHM）市場について調査分析し、市場および業界展望、セグメント別・地域別市場の展望の他、競合情勢について、体系的な情報を提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、範囲

• 市場セグメンテーション
• 市場力学
• 米国の集団健康管理（PHM）市場：ビジネス環境分析ツール
• 浸透と成長の展望のマッピング
• 規制シナリオと償還フレームワーク
• COVID-19パンデミックの影響：定性分析

第4章 米国の集団健康管理（PHM）市場：製品別分析

• 米国の集団健康管理（PHM）の製品別市場シェア分析、2020年および2028年
• 米国の集団健康管理（PHM）の製品別市場：セグメントダッシュボード
• 製品別セグメントの市場規模と予測および動向分析、2016年～2028年

第5章 米国の集団健康管理（PHM）市場：最終用途分析

• 米国の集団健康管理（PHM）の最終用途別市場シェア分析、2020年および2028年
• 米国の集団健康管理（PHM）の最終用途別市場：セグメントダッシュボード
• 最終用途セグメントの市場規模と予測および動向分析、2016年～2028年

第6章 競合分析

• 戦略的フレームワーク/競合の分類（主要なイノベーター、マーケットリーダー、新興企業）
• ベンダー情勢
  • 企業の市況分析
• 米国のPHMベンダーのリスト
• 主要な企業プロファイル
  • Allscripts Healthcare, LLC
  • Cerner Corporation
  • Conifer Health Solutions, LLC
  • eClinicalWorks
  • Enli Health Intelligence
  • McKesson Corporation
  • Medecision
  • Optum, Inc.
  • Advisory Board
  • Koninklijke Philips N.V.
  • athenahealth, Inc.
  • RedBrick Health Corporation
  • Welltok

List of Tables

• 1. List of secondary sources
• 2. List of abbreviation
• 3. U.S. Population Health Management Market, by Product, 2017 - 2030 (USD Billion)
• 4. U.S. Population Health Management Market, by End Use, 2017 - 2030 (USD Billion)

List of Figures

• 1. U.S. population health management (PHM) market segmentation
• 2. Market research process
• 3. Information procurement
• 4. Primary research pattern
• 5. Market research approaches
• 6. Value chain based sizing & forecasting
• 7. QFD modelling for market share assessment
• 8. Market formulation & validation
• 9. U.S. population health management (PHM) market outlook, 2021 (USD Billion)
• 10. Market trends & outlook
• 11. Market driver relevance analysis (Current & future impact)
• 12. Market restraint relevance analysis (Current & future impact)
• 13. Penetration & growth prospect mapping
• 14. U.S. Population Health Management (PHM) product market share analysis, (USD Billion)
• 15. U.S. population health management (PHM) market: Product segment dashboard
• 16. Software market, 2017 - 2030 (USD Billion)
• 17. Services market, 2017 - 2030 (USD Billion)
• 18. U.S. population health management (PHM) end use market share analysis, (USD Billion)
• 19. U.S. population health management (PHM) market: End use segment dashboard
• 20. Providers market, 2017 - 2030 (USD Billion)
• 21. Payers market, 2017 - 2030 (USD Billion)
• 22. Employer groups market, 2017 - 2030 (USD Billion)
• 23. Impact analysis by key market participants
• 24. Company/competition categorization
• 25. Company market position analysis

U.S. Population Health Management Market Growth & Trends:

The U.S. population health management market size is expected to reach USD 103.7 billion in 2030, registering a CAGR of 19.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increase in healthcare expenditure, need for value-based healthcare delivery, and effective disease management across different care settings are among the key factors expected to drive the market during the forecast period.

In the U.S., poor healthcare management results in the loss of productivity and a significant portion of healthcare costs. Adoption of PHM software by employers helps in the management of their healthcare budget as they can keep a track of the employees' health status. The market is likely to witness rapid growth in the coming years due to the growing demand for healthcare IT services and solutions that encourage healthcare delivery reliant on value, resulting in a transition from Fee-For-Service to a value-based payment model.

Population health management is built on a Fee-for-Service (FFS) reimbursement method, wherein physicians and other healthcare providers are reimbursed by government agencies and insurance companies on basis of the number of services offered to patients. The new payment model allows reimbursement based on the quality of care delivered and provides comprehensive tools to handle financial and clinical risk for value-based care delivery.

The COVID-19 pandemic has changed the outlook of healthcare in the U.S. with the advanced use of web-based technology in healthcare. Healthcare providers are increasingly investing in PHM software to offer better outcomes. PHM can also be used for tracking the vital signs of patients discharged from hospitals, which can then be analyzed to offer meaningful insights into a patient's health. The lockdown has disrupted the existing system and PHM systems are the current need to manage the patient population.

U.S. Population Health Management Market Report Highlights:

• An increase in healthcare expenditure, the need for value-based healthcare delivery, and effective disease management across different care settings is expected to drive the market

• The services segment dominated the global market in 2021, while the software segment is likely to register the fastest CAGR over the forecast period

• The market is now shifting to a value-based payment model. The value-based contracts are expected to grow substantially in the coming years

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Estimates and Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary research
• 1.4 Information or Data Analysis
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity flow analysis
• 1.7 List of Secondary Sources
• 1.8 List of Abbreviations
• 1.9 Research Objectives
  • 1.9.1 Objective - 1
  • 1.9.2 Objective - 2
  • 1.9.3 Objective - 3

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
  • 2.2.1 Product
  • 2.2.2 End Use
• 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

• 3.1 Market Dynamics
  • 3.1.1 Market Driver Analysis
    • 3.1.1.1 Growing demand for value-based healthcare delivery
    • 3.1.1.2 Rising healthcare expenditure
    • 3.1.1.3 Need for effective disease management across different care settings
    • 3.1.1.4 Rapidly aging population in the U.S.
  • 3.1.2 Market Restraint Analysis
    • 3.1.2.1 Lack of proper regulatory framework for PHM
    • 3.1.2.2 High cost and challenges related to treatment model
• 3.2 U.S. Population Health Management (PHM) Market: Business Environment Analysis Tools
  • 3.2.1 Porter's Five Forces Analysis
    • 3.2.1.1 Threat of new entrants: Moderate to High
    • 3.2.1.2 Threat of substitutes: High
    • 3.2.1.3 Competitive rivalry: High
    • 3.2.1.4 Bargaining power of suppliers: High
    • 3.2.1.5 Bargaining power of buyers: Low
  • 3.2.2 PESTEL Analysis
    • 3.2.2.1 Political & Legal
    • 3.2.2.2 Economic
    • 3.2.2.3 Technological
• 3.3 Penetration & Growth Prospect Mapping
• 3.4 Regulatory Scenario & Reimbursement Framework
• 3.5 COVID-19 Pandemic Impact: Qualitative Analysis

Chapter 4 U.S. Population Health Management (PHM) Market: Product Analysis

• 4.1 U.S. Population Health Management (PHM) Product Market Share Analysis, 2021 & 2030
• 4.2 U.S. Population Health Management (PHM) Market: Product Segment Dashboard
• 4.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Product Segment
  • 4.3.1 Software
    • 4.3.1.1 Software market, 2017 - 2030 (USD Billion)
  • 4.3.2 Services
    • 4.3.2.1 Services market, 2017 - 2030 (USD Billion)

Chapter 5 U.S. Population Health Management (PHM) Market: End Use Analysis

• 5.1 U.S. Population Health Management (PHM) End Use Market Share Analysis, 2021 & 2030
• 5.2 U.S. Population Health Management (PHM) Market: End Use Segment Dashboard
• 5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End Use Segment
  • 5.3.1 Providers
    • 5.3.1.1 Providers market, 2017 - 2030 (USD Billion)
  • 5.3.2 Payers
    • 5.3.2.1 Payers market, 2017 - 2030 (USD Billion)
  • 5.3.3 Employer Groups
    • 5.3.3.1 Employer Groups market, 2017 - 2030 (USD Billion)

Chapter 6 Competitive Analysis

• 6.1 Recent Developments & Impact Analysis, by Key Market Participants
• 6.2 Company/Competition Categorization
• 6.3 Company Market Position Analysis
• 6.4 List of Few PHM Vendors in the U.S.
• 6.5 Company Profiles
  • 6.5.1 ALLSCRIPTS HEALTHCARE, LLC
    • 6.5.1.1 Company overview
    • 6.5.1.2 Financial performance
    • 6.5.1.3 Product benchmarking
    • 6.5.1.4 Strategic initiatives
  • 6.5.2 CERNER Corporation
    • 6.5.2.1 Company overview
    • 6.5.2.2 Financial performance
    • 6.5.2.3 Product benchmarking
    • 6.5.2.4 Strategic initiatives
  • 6.5.3 CONIFER HEALTH SOLUTIONS, LLC
    • 6.5.3.1 Company overview
    • 6.5.3.2 Financial performance
    • 6.5.3.3 Product benchmarking
    • 6.5.3.4 Strategic initiatives
  • 6.5.4 ECLINICALWORKS
    • 6.5.4.1 Company overview
    • 6.5.4.2 Financial performance
    • 6.5.4.3 Product benchmarking
    • 6.5.4.4 Strategic initiatives
  • 6.5.5 Cedar Gate Technologies
    • 6.5.5.1 Company overview
    • 6.5.5.2 Financial performance
    • 6.5.5.3 Product benchmarking
    • 6.5.5.4 Strategic initiatives
  • 6.5.6 MCKESSON CORPORATION
    • 6.5.6.1 Company overview
    • 6.5.6.2 Financial performance
    • 6.5.6.3 Product benchmarking
    • 6.5.6.4 Strategic initiatives
  • 6.5.7 MEDECISION
    • 6.5.7.1 Company overview
    • 6.5.7.2 Financial performance
    • 6.5.7.3 Product benchmarking
    • 6.5.7.4 Strategic initiatives
  • 6.5.8 OPTUM, INC.
    • 6.5.8.1 Company overview
    • 6.5.8.2 Financial performance
    • 6.5.8.3 Product benchmarking
    • 6.5.8.4 Strategic initiatives
  • 6.5.9 ADVISORY BOARD
    • 6.5.9.1 Company overview
    • 6.5.9.2 Financial performance
    • 6.5.9.3 Strategic initiatives
  • 6.5.10 KONINKLIJKE PHILIPS N.V.
    • 6.5.10.1 Company overview
    • 6.5.10.2 Financial performance
    • 6.5.10.3 Product benchmarking
    • 6.5.10.4 Strategic initiatives
  • 6.5.11 ATHENAHEALTH, INC.
    • 6.5.11.1 Company overview
    • 6.5.11.2 Financial performance
    • 6.5.11.3 Product benchmarking
    • 6.5.11.4 Strategic initiatives
  • 6.5.12 REDBRICK HEALTH CORPORATION
    • 6.5.12.1 Company overview
    • 6.5.12.2 Financial performance
    • 6.5.12.3 Product benchmarking
    • 6.5.12.4 Strategic initiatives
  • 6.5.13 WELLTOK
    • 6.5.13.1 Company overview
    • 6.5.13.2 Financial performance
    • 6.5.13.3 Product benchmarking
    • 6.5.13.4 Strategic initiatives